Vitamin K2 for Vitamin D Deficiency

Vitamin K2 is often sold alongside vitamin D on the premise that it directs calcium into bone. It does not correct vitamin D deficiency and the clinical evidence for co-supplementation is thin.

Overview

Vitamin K2 is often sold alongside vitamin D on the premise that it directs calcium into bone. It does not correct vitamin D deficiency and the clinical evidence for co-supplementation is thin.

Verdict

Insufficient evidence

K2 does nothing to raise vitamin D status. Its bone and vascular claims remain unproven in people with adequate K intake.

How It Works

Vitamin K2 acts as a cofactor for gamma-carboxylation of osteocalcin and matrix Gla protein, proteins involved in bone mineralisation and inhibition of vascular calcification. The theory holds that raising calcium absorption with vitamin D without adequate K2 could favour arterial rather than skeletal deposition.

Dosing & Protocol

Typical dose

Recommended dose: 90-180 mcg MK-7 daily where used
Expected timeframe: No timeframe applies to vitamin D status. Carboxylation markers change within four to eight weeks if measured.

Protocol

form: Not applicable
duration: Not applicable
co factor: Evidence is insufficient, and the framing needs correcting: vitamin K2 cannot raise 25-hydroxyvitamin D or treat vitamin D deficiency - only vitamin D can do that. The real claim behind combined D3+K2 products is different: vitamin K2 (MK-7, typically 90-180 mcg/day) carboxylates matrix Gla protein and osteocalcin, and the theory is that it directs calcium mobilised by vitamin D into bone rather than arteries. That theory is plausible and supported by mechanistic and observational data, but no randomised trial shows that adding K2 to vitamin D improves fractures, arterial calcification or clinical outcomes.
titration: Not applicable
starting dose: Not applicable

Evidence

What the studies say

The mechanistic story is coherent but clinical confirmation is weak. Trials of MK-7 have shown improved carboxylation of osteocalcin and matrix Gla protein, which are biochemical rather than clinical endpoints. Bone density effects have been small and inconsistent outside Japanese studies of high-dose MK-4, which have not replicated well elsewhere. No trial demonstrates that adding K2 to vitamin D reduces fracture or cardiovascular events in Western populations with typical dietary vitamin K intake, and importantly, K2 does not alter serum 25-OH-D at all. For a person with documented deficiency, K2 addresses none of the problem.

No studies are yet linked to both Vitamin K2 and Vitamin D Deficiency.

Safety

Caveats

Vitamin K antagonises warfarin and must be avoided or carefully managed in anyone on that drug. Combination D+K products can obscure how much vitamin D you are actually taking.

Less likely to help if

Anyone whose goal is correcting a low 25-OH-D. People with adequate dietary vitamin K from leafy greens and fermented foods are unlikely to gain anything.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.